论文部分内容阅读
目的:探讨微创穿刺治疗幕上高血压脑出血(HICH)的手术时机与疗效。方法:回顾性分析2008年3月至2011年3月广东省河源市人民医院收治的92例血肿量为30～60 mL的幕上HICH患者的临床资料,患者均行微创穿刺配合尿激酶液化引流术,根据发病至治疗时间不同分为A组44例(脑出血时间≤6 h)和B组48例(脑出血时间6～24 h),比较两组患者的再出血率、病死率和痊愈率。结果:两组患者再出血率、病死率比较,差别无统计学意义(P>0.05);A组患者的痊愈率为85.4%,高于B组的65.2%(P<0.05)。结论:超早期微创穿刺配合尿激酶液化引流术治疗血肿量为30～60 mL的幕上HICH安全、有效。
Objective: To investigate the timing and effect of minimally invasive puncture in the treatment of supratentorial hypertensive intracerebral hemorrhage (HICH). Methods: The clinical data of 92 supratentorial HICH patients with a hematoma volume of 30-60 mL admitted from March 2008 to March 2011 in Heyuan City People’s Hospital of Guangdong Province were retrospectively analyzed. Patients underwent minimally invasive puncture combined with liquefaction The patients were divided into group A (44 cases), group B (48 cases) and group B (24-24 hours) according to the time from onset to treatment. The rates of rebleeding, mortality and Cure rate Results: There was no significant difference in rebleeding rate and mortality between the two groups (P> 0.05). The cure rate of group A was 85.4%, which was higher than that of group B (65.2%, P <0.05). Conclusion: Ultra-early minimally invasive puncture with urokinase liquefaction and drainage is safe and effective in treating supratentorial HICH with hematoma volume of 30-60 mL.